Abstract: α-Glucans from bacterial exo-polysaccharides or diet, e.g., resistant starch, legumes and honey are abundant in the human gut and fermentation of resistant fractions of these α-glucans by probiotic lactobacilli and bifidobacteria impacts human health positively. The ability to degrade polymeric α-glucans is confined to few strains encoding extracellular amylolytic activities of glycoside hydrolase (GH) family 13. Debranching pullulanases of the subfamily GH13 14 are the most common extracellular GH13 enzymes in lactobacilli, whereas corresponding enzymes are mainly α-amylases and amylopullulanases in bifidobacteria. Extracellular GH13 enzymes from both genera are frequently modular and possess starch binding domains, which are important for efficient catalysis and possibly to mediate attachment of cells to starch granules. α-1,6-Linked glucans, e.g., isomalto-oligosaccharides are potential prebiotics. The enzymes targeting these glucans are the most abundant intracellular GHs in bifidobacteria and lactobacilli. A phosphoenolpyruvate-dependent phosphotransferase system and a GH4 phospho-α-glucosidase are likely involved in metabolism of isomaltose and isomaltulose in probiotic lactobacilli based on transcriptional analysis. This specificity within GH4 is unique for lactobacilli, whereas canonical GH13 31 α-1,6-glucosidases active on longer α-1,6-gluco-oligosaccharides are ubiquitous in bifidobacteria and lactobacilli. Malto-oligosaccharide utilization operons encode more complex, diverse, and less biochemically understood activities in bifidobacteria compared to lactobacilli, where important members have been recently described at the molecular level. This review presents some aspects of α-glucan metabolism in probiotic bacteria and highlights vague issues that merit experimental effort, especially oligosaccharide uptake and the functionally unassigned enzymes, featuring in this important facet of glycan turnover by members of the gut microbiota.
Introduction
The intimate association between microbes and humans (and other animals) has been increasingly recognized as a major factor affecting the co-evolution, physiology, and metabolic interplay between both classes of organisms (Ley et al. 2008; McFall-Ngai et al. 2013) . Humans consist of their own somatic cells only until birth, but in conjunction with delivery the newborn are inoculated with microbes that proliferate to establish vast and complex communities in the gastrointestinal tracts (GI) and at other sites of the body. The gut microbial community develops rapidly in the newborn and stabilizes after two to three years (Morgan et al. 2013) , forming one of the most densely populated ecological niches in nature (Eckburg et al. 2005) . The gut microbiota is dominated by mainly four bacterial phyla with Firmicutes being the most abundant followed by Bacteroidetes, Actinobacteria and Proteobacteria (Arumugam et al. 2011 ). This lower complexity at phylum level belies the true diversity of the gut microbiota, that comprises an excess of 100 species (varies according to study and protocol used) (Faith et al. 2013) and which is unique to each individual. Common to all humans, however, is that imbalance in the gut microbiota (dysbiosis) as compared to the status-quo attained in the early years of life, is associated with serious disorders including obesity, diabetes, bowel cancer, and allergies ( Wallace et al. 2011; Kootte et al. 2012; Sommer & Baeckhed 2012 ). The precise composition of the gut microbiota is governed by a variety of factors, e.g., age, genetics, method of delivery and lifestyle (Nicholson et al. 2012) . Despite the apparent stability of the gut microbiota through adulthood, it remains dynamic being able to respond to perturbations through changes in its composition reflected at the species level and in the ratio between different phyla, which has been demonstrated to be of significance to health and disease risks (Clemente et al. 2012 ). An obvious example of such perturbations is changes in diet, which has been shown to alter the composition of the microbiota (Scott et al. 2013) .
Humans possess remarkably limited saccharolytic machinery being only able to hydrolyze glycosidic bonds in sucrose, lactose and to a certain extent starch by their digestive enzymes (Cantarel et al. 2012) , rendering most glycans essentially non-digestible to humans. On the other hand, human diet contains large quantities of glycans in cereals, fruits and vegetables, most of which reach the distal gut (colon) intact and are harvested by the gut microbiota to generate metabolic fuel. This is in accord with the important role that glycan metabolism plays in modulating the composition of the gut microbiota, and the inherent impact of this on health Muegge et al. 2011; Scott et al. 2013) .
Starch, which is an exclusively α-glucan polymer organized in supramolecular insoluble semicrystalline granules (Tester et al. 2004) , is the most abundant glycan in human diet. Although humans possess the enzymatic machinery for starch breakdown (mainly the α-1,4-glycosidic bonds), the degradability of this polymer varies considerably based on botanic origin and fine structural details, especially crystal-packing (Blazek & Gilbert 2010) . Thus, significant amounts of dietary resistant starch (RS) reach the distal colon where they are fermented by members of the gut microbiota (FuentesZaragoza et al. 2011) . Other dietary sources of α-glucans likely to reach the colon intact are α-1,6-linked gluco-oligosaccharides (often designated as isomaltooligosaccharides; IMOs) from legumes and honey (Goffin et al. 2011) , as these glucans are non-digestible for humans except for the disaccharide isomaltose (α-d-Glcp-(1,6)-d-Glcp). Beside dietary intake, capsular polysaccharides or exo-polysaccharides produced by members of the gut bacterial community (Duboc & Mollet 2001 ) (or acquired via bacterial food contaminants) comprise another class of α-glucan substrates that are available to support bacterial growth in the gut niche.
Specific groups of gut microbiota, mainly belonging to the Lactobacillus and Bifidobacterium genera, have been shown to confer a variety of health benefits including pathogen exclusion and alleviation of inflammatory bowel disease, colon cancer, and allergies Tang et al. 2010; Whelan 2011) . These health promoting probiotic bacteria have been shown to be selectively stimulated by a variety of non-digestible β-linked oligo-and, to a less extent, poly-saccharides acting as prebiotics, e.g., galacto-oligosaccharides, xylooligosaccharides and fructo-oligosaccharides (de Vrese & Schrezenmeir 2008; Rastall 2010) . Interestingly, α-1,6-gluco-oligosaccharides possess prebiotic potential as judged by preferential stimulation of probiotic bacteria and improved bowel function (Kaneko et al. 1994 , Yen et al. 2011 . Additionally, a recent report suggests that RS resulted in significant increase in lactic acid production and a change in the Bacteroidetes/Firmicutes ratio in fecal in vitro fermentations, supplemented with the probiotic strain Lactobacillus acidophilus NCFM (Knudsen et al. 2013) . These data are consistent with the importance of α-glucan metabolism in probiotic bacteria, which is also reflected by the notably high representation of glycoside hydrolase (GH) family 13 genes that are pivotal in α-glucan metabolism by probiotic bacteria as compared to other GH families according to the mechanism and sequence-based Carbohydrate-Active enZymes (CAZy) classification system (http://www.cazy.org/) (Cantarel et al. 2009 ).
Considering the importance of probiotic bacteria in the context of human health and the interest in noninvasive manipulation of the gut microbiota composition for therapeutic purposes, surprisingly little attention has been dedicated to α-glucan metabolism in probiotic bacteria and many aspects of this part of their glycan metabolism remain ill-understood. In the present review, we survey the content of GH13 in genomes of genera harbouring probiotic strains and highlight recent insight into the routes of uptake and metabolism of selected α-glucans. Recent work on glycogen metabolism in probiotic lactobacilli, which is of relevance to fitness in the highly competitive and dynamic niche of the gut is also presented.
A genomic survey of GH13 α-glucan active CAZymes in Lactobacillus and Bifidobacterium: a snapshot into α-glucan metabolism potential At present, the family GH13 includes the vast majority of α-glucan-active enzymes in the CAZy database (>15,800 sequences), making this family a good probe for metabolic capabilities in relation to α-glucans. This section focuses on the distribution of the GH13 CAZymes in the Lactobacillus and Bifidobacterium, which casts light on the commonalities and differences in the enzymology of α-glucan processing from a genomic perspective. Other selected CAZy families with important activities relevant to α-glucan metabolism will be mentioned later in other sections, but a comprehensive analysis of these is beyond the scope of the review.
All GH13 entries from annotated genomes of lactobacilli and bifidobacteria were retrieved from CAZy. At the time of the analysis, 315 and 326 entries were retrieved from 32 Bifidobacterium and 58 Lactobacillus genomes, respectively. Thus, GH13 is the largest family based on the average GH13 number per genome (9.8 and 11 in Bifidobacterium and Lactobacillus, respectively) emphasizing the importance of α-glucan metabolism in large subsets of lactobacilli and bifidobacteria. The abundance of GH13, however, seems to be species and strain dependent, which is informative from a niche adaptation point of view. For example, milk adapted Lactobacillus strains, e.g., Lactobacillus fermentum CECT 5716 and L. fermentum F-6 possess only one GH13 enzyme and the meat adapted Lactobacillus sakei subsp. sakei 23K possesses two, as compared to 7-9 GH13 members in the gut adapted acidophilus cluster lactobacilli, e.g., the characterized probiotic L. acidophilus NCFM (Sanders & Klaenhammer 2001) . The same applies in bifidobacteria, e.g., Bifidobacterium asteroides PRL2011 from insect (honey bee) gut has the lowest GH13 arsenal of all bifidobacteria (4 sequences).
Interestingly, there is a fairly large proportion of GH13 enzymes, which are not assigned into a subfamily (subfamilies in a GH are assigned based on primary structure similarities and members of a subfamily are often functionally related; Stam et al. 2006 ) and more so in Lactobacillus than in Bifidobacterium (Fig. 1A) . Some of these enzyme sequences represent known specificities, but are too distant from characterized counterparts to enable reliable subfamily assignment. Other sequences are expected to confer novel activities that remain to be discovered. Further experimental work is required to illuminate the biochemical properties of functionally unassigned enzyme sequences and their role in α-glucan turnover in these two important genera.
Another notable observation is the high representation of subfamily 31 (GH13 31) in the GH13 repertoires of both Lactobacillus and Bifidobacterium, mounting almost to 30% of all GH13 members in lactobacilli (Fig. 1A ). This subfamily contains α-1,6-glucosidases that confer the utilization of α-1,6-containing gluco-oligosaccharides (IMOs and panose), consistent with the prebiotic effect of this type of glucans that endow probiotic bacteria with a competitive edge due to their preferential fermentation (Kaneko et al. 1994; Yen et al. 2011; Møller et al. 2012) . Other subfamilies that are highly represented in both genera are GH13 18 sucrose phosphorylases and GH13 9 1,4-α-glucan branching enzymes (Fig. 1A) . The former subfamily confers the phosphorolysis of sucrose moieties including those derived from soybean oligosaccharides of the raffinose family, which are also suggested to be prebiotics (Fredslund et al. 2011; Andersen et al. 2012) , whereas the branching enzymes of the latter subfamily GH13 9 are involved in glycogen synthesis . Some subfamilies are uniquely encountered in Lactobacillus, e.g., GH13 20 maltogenic α-amylases that are frequently present in the malto-oligosaccharide metabolism operons in lactobacilli (Nakai et al. 2009; Møller et al. 2012) , while others are unique for bifidobacteria, e.g., predicted extracellular α-amylases of GH13 32 and modular amylopullulanases containing both GH13 14 and GH13 32 catalytic modules (Fig. 1A, Fig. 2 ). The diversity of subfamilies is larger in bifidobacteria, as compared to lactobacilli (Fig. 1B,C) , which can be partially explained by: (i) larger ratio of unassigned sequences in lactobacilli which will be eventually assigned into . At the time of analysis 315 and 326 entries were retrieved from bifidobacteria (black bars) and lactobacilli (grey bars), respectively. The GH13 statistics give insight into the representation of certain subfamilies, and thereby indicate the genomic potential of these two genera to catabolize specific α-glucan bonds. (B) Subfamily distribution amongst putative extracellular GH13 entries as predicted using SignalP (see text) from lactobacilli (9 entries). (C) Predicted extracellular GH13 enzymes from bifidobacteria (9 entries). Modular putative extracellular GH13 enzymes frequently contain an α-amylase catalytic domain in bifidobacteria, whereas extracellular GH13 enzymes of lactobacilli are mainly pullulanases. new subfamilies when biochemical data becomes available; and (ii) more extensive occurrence of α-glucan enzymes from other GH families in lactobacilli, e.g., GH4 (contains both α-glucosidases and 6'-phospho-α-glucosidases) and GH65 (contains di-glucosyl phosphorylases). Additional biochemical data is needed to precisely compare the metabolic reach of the gut adapted species of lactobacilli and bifidobacteria.
Extracellular secreted GH13 and starch utilization by probiotic bacteria The best studied starch utilization system in the gut niche is from species of the dominant commensal (symbiont) genus Bacteroides (Cameron et al. 2012 ). By contrast, the starch utilization capabilities of lactobacilli and bifidobacteria are less well documented. The production of amylolytic extracellular enzymes is necessary for the utilization of both granular starch, and polymeric components thereof, as these large substrates need to be degraded to smaller oligosaccharides to allow efficient uptake by glycan specific transporters. Therefore, analysis of the extracellular GH13 content is informative to assess the amylolytic potential of different organisms. We analysed the putative extracellular GH13 in lactobacilli and bifidobacteria by submitting all the retrieved GH13 sequences to the SignalP server to predict the presence of secretion transit peptides (http://www.cbs.dtu.dk/services/SignalP/). Only 9 sequences from either Lactobacillus or Bifidobacterium were predicted to be extracellular, which corresponds to about 2.9% of the GH13 entries in each group. This low abundance of extracellular amylolytic enzymes suggests that the ability to degrade starch or polymeric starchy substrates is confined to a few strains within these taxa.
α-Glucan metabolism in probiotic bacteria
Notably, most extracellular GH13 CAZymes from Bifidobacterium contained putative α-amylase catalytic domains from subfamily 28 or 32 (the role of subfamily 3 modules in bifidobacteria is currently unknown), whereas the α-1,6-debranching pullulanases of GH13 14 were dominant in lactobacilli, especially those acidophilus group members that are adapted to the human gut (Fig. 1B,C, Fig. 2) . The rareness of α-amylases in lactobacilli is consistent with only 11 of 96 species reported to degrade starch (Petrova et al. 2013) , in a highly strain dependent manner. The majority of the extracellular GHs were modular featuring domains of unknown function, cell attachment modules, starch binding domains assigned into carbohydrate binding module (CBM) families 25, 26, 41, and 48 (Christiansen et al. 2009) (Fig. 2) appended to catalytic GH13 modules. The wide occurrence of starch binding domains in these enzymes suggests that binding to the substrate is functionally important for catalysis, which has been shown in the α-amylases from L. amylovorus and L. plantarum (Rodriguez-Sanoja et al. 2005) . In a competitive niche as the gut, another important function of CBMs is plausibly to mediate attachment between the cells (via cell displayed modular enzymes) and supramolecular substrates such as starch granules. We are currently investigating this hypothesis in the cell attached modular pullulanase from L. acidophilus NCFM (Fig. 2) , which is essentially inactive on starch granules (M.S. Møller et al., unpublished data) . This organism is unable to grow on starch or other larger glucans, thus the role of this enzyme is intriguing and affords interrogation. Theoretically this enzyme could associate to starch granules via the CBM41 domain, but this needs experimental corroboration. Binding of bacterial cells to starch granules (the site of primary degradation) may provide a competitive advantage by promoting cross-feeding on smaller α-glucans (di-and tri-saccharides) that escape capture by other organisms. Further work is required to investigate this possibility.
Metabolism of α-1,4-and α-1,6-glucooligosaccharides
Probiotic lactobacilli and bifidobacteria are able to grow on different α-gluco-oligosaccharides (Sanz et al. 2005; Sarbini et al. 2013) . Probiotic bacteria can acquire these substrates either directly from the host diet, by cross feeding from primary degraders (Flint et al. 2007) or more rarely by the action of their own extracellular GH13 enzymes. In all cases, the strategy adopted by probiotic bacteria is to rely on different classes of transport systems for efficient uptake of diand oligo-saccharides, which is followed by complete depolymerisation by intracellular hydrolases and accessory enzymes (Abou ). Typically, but not invariantly, the genes encoding these transport systems, hydrolases and transcriptional regulator are clustered together in functional operons.
We have investigated the routes of utilization of both α-1,4-malto-oligosaccharides and α-1,6-IMOs in the probiotic L. acidophilus NCFM and in Bifidobacterium animalis subsp. lactis Bl-04 (Barrangou et al. 2009 ), which represents a widely used probiotic subspecies within the genus due to its technological and health promoting properties ( (Loquasto et al. 2013) .
In L. acidophilus NCFM, the malto-oligosaccharide gene cluster encodes a transcriptional regulator (MalR), acetate kinase (AckA), a GH13 of unknown function (MalL), a GH13 20 maltogenic α-amylase (MalN), a GH65 maltose phosphorylase (MalP), a phosphoglucomutase (PgmB) and an ATP-binding cassette (ABC) transport system (Msmk, MalE, MalF, MalG) (Nakai et al. 2009 ). This arrangement is highly conserved across species in the genus with the main difference being that in other species, the gene cluster also includes a GH13 31 glucan α-1,6-glucosidase that catalyses the hydrolysis of IMOs including panose. Recently, the glucan α-1,6-glucosidase from L. acidophilus NCFM, which is encoded by a separate genetic locus than the malto-oligosaccharide operon, has been biochemically and structurally characterized providing the first insight into the enzymology α-1,6-glucosidases from lactobacilli (Møller et al. 2012 ). The frequent colocalization of α-1,6-glucosidase genes in the maltooligosaccharide operon in most lactobacilli raises the question of whether the same ABC transport system is able to confer uptake of both IMOs and maltooligosaccharides, but experimental evidence is needed to verify this.
Another interesting enzyme encoded by the maltooligosaccharide operon in lactobacilli is the GH65 maltose phosphorylase (MalP). We have provided experimental evidence for the functionality of this enzyme from L. acidophilus NCFM (Nakai et al. 2009 ). The enzyme also proved very useful as a synthetic tool for the synthesis of a variety of di-saccharides with an α-glucosyl residue at the non-reducing end including some non-naturally occurring compounds, e.g., α-Glcp-(1,4)- Manp, α-Glcp-(1,4)-Xylp and α-Glcp-(1,4)-l-Fucp (Nakai et al. 2009) . Surprisingly, some of these compounds produced by this enzyme selectively stimulated the growth of B. animalis subsp. lactis Bl-04 as compared to two other probiotic strains and a commensal strain in vitro suggesting that this approach may be a viable one to engineer novel prebiotic compounds (Vigsnaes et al. 2013 ). This also suggests that some the uptake systems possess a degree of promiscuity, which can be exploited in design of novel prebiotic oligosaccharides.
Whole genome microarray transcriptional analysis suggested a novel route for the uptake of isomaltose, isomaltulose (α-d-Glcp-(1,6)-d-Fruf) and possibly panose in L. acidophilus NCFM, as two loci encoding a phosphoenoylpyruvate-dependant phosphotransferase transport system (PTS) and a GH4, respectively, were highly up-regulated in response to growth on these saccharides (Andersen et al. 2012) . Uptake through PTS systems is concomitant with phosphorylation of the internalised glycan (mainly di-saccharides) at the 6'-hydroxyl moiety. These phosphorylated substrates are recognized by special GH4 glycosidases. The isomaltose responsive GH4 which resides on a separate locus different from the PTS uptake system, is currently annotated as a maltose 6'-phospho-glucosidase. However, the transcriptomic data and sequence homology to a characterized enzyme from Lactobacillus casei ATCC 334 active on phosphorylated sucrose isomers (66% identity) suggest that the physiologically relevant substrate for this enzyme is not maltose, since the enzyme from L. casei ATCC 334 was repressed upon growth on sucrose and maltose (Thompson et al. 2008) . Nonetheless, the enzyme from L. casei was active on 6'-phosphomaltose in vitro, albeit displaying five-fold lower specific activity as compared to 6'-phospho-isomaltulose. Phylogenetic analysis of all bacterial GH4 members showed that the GH4 from L. acidophilus NCFM and the homologue from L. casei ATCC 334 reside on an exclusively Lactobacillus populated cluster of phospho-α-glucosidases (Abou ). Interestingly, GH4 sequences from other lactobacilli including other L. casei strains cluster more closely to other characterized phospho-α-glucosidases showing high activity on 6'-phospho-maltose as compared to 6'-phosphoisomaltulose or 6'-phospho-isomaltose (Fig. 3) . Altogether, this suggests that GH4 phospho-α-glucosidases from gut adapted lactobacilli may have a preference for phosphorylated isomaltose and other sucrose isomers rather than 6'-phospho-maltose, as shown for some organisms from the soil niche and human pathogens.
The diversity of α-glucan metabolism capabilities seems to be higher in bifidobacteria with regard to both genetic organization and the type of transporters and hydrolases. A notable difference from lactobacilli is the co-localization and co-transcription of GH13 31 and GH36 1 α-galactosidase genes responsible for the metabolism of IMOs and galactosides, respectively . The presence of genes encoding an ABC transport system within this operon is suggestive of a dual α-1,6-glycoside specificity of this transport system. Currently we are investigating the biochemical and structural features of the solute binding protein mediating the capture of these substrates for translocation via this ABC system.
With regard to α-1,4-maltodextrins, the picture is more complicated. Transcriptional analysis identified a locus harbouring genes for two ABC transport systems, a GH13 30 α-glucosidase, a GH13 14 pullulanase, a putative 4-α-glucanotransferase of GH77 and a GH13 member of unknown function . Only one of the solute binding proteins associated with one of the ABC transport systems (locus tag number Balac 1565) shows a distant relationship to the canonical maltose binding proteins, whereas the second solute binding protein is not homologous to known malto-dextrin specific binding proteins. Interestingly the presence of these two ABC import systems is conserved in the B. animalis species and in other bifidobacteria, e.g., Bifidobacterium thermophilum RBL67 and Bifidobacterium dentium Bd1. These observations merit the biochemical characterisation of these transport systems and the functionally ambiguous hydrolases to establish a more robust understanding of which and how α-glucans are internalised and processed by probiotic bifidobacteria.
Glycogen metabolism in Lactobacillus
Glycogen synthesis in bacteria involves glucose-1-phosphate adenylyltransferase (GlgC or GlgCD), a glycosyl transferase (GT) family 5 glycogen synthase (GlgA) and glycogen-branching enzyme of GH13 9 (GlgB). Glucose-1-phosphate serves as a substrate for ADP-glucose synthesis catalyzed by GlgC or GlgCD. Then, GlgA catalyzes the transfer of glucosyl units from ADP-glucose to the elongating chain of linear α-1,4-glucan, where GlgB subsequently transfers a fragment of the glucan chains to form frequent α-1,6-branches characteristic to the glycogen structure. Glycogen catabolism involves glycogen phosphorylase of GT35 (GlgP) and glycogen-debranching enzyme of GH13 (GlgX). The glycogen phosphorylase catalyzes the phosphorolytic breakdown of the glucan chain, whereas the debranching of limit dextrins produced by the action of the phosphorylase is carried out by the debranching enzyme. Glycogen metabolism contributes to energy storage and other physiological functions in some prokaryotes, including colonization persistence (Jones et al. 2008; Busuioc et al. 2009) , and serves as a carbon capacitor that regulates downstream carbon fluxes (Belanger & Hatfull 1999) . In addition, glycogen metabolism is involved in major cellular processes, such as carbohydrate metabolism, energy production, stress response and cell-cell communication (Eydallin et al. 2007; Eydallin et al. 2010) . Altogether, available data suggest that glycogen metabolism potentially contributes to the survival and probiotic activities of lactobacilliand possibly other probiotic microorganisms in the GI environment.
The first example of a functional glycogen metabolism pathway in probiotic lactic acid bacteria (LAB) was recently demonstrated in L. acidophilus NCFM . The pathway is encoded by an operon, designated as the glg operon, and consists of glgB, glgCD, glgA, glgP, amy (annotated as a putative α-amylase, but is more likely to have a debranching activity) and pgm (putative phosphoglucomutase) genes. The co-transcription of these genes indicates that glycogen synthesis and degradation occur in parallel and may play a role in regulating the carbon flow inside the cells. Similar glg operons were found only in specific Lactobacillus species commonly associated with mammalian hosts or natural environments. The proposed nichespecific function of glycogen metabolism was further highlighted by the inter-strain comparison among Lactobacillus helveticus and Lactobacillus delbrueckii ssp. bulgaricus, whereby the pathway was identified in a probiotic strain and a human isolate of L. helveticus and L. bulgaricus, respectively, but not in their dairyassociated counterparts .
In L. acidophilus, expression of the glg operon and Fig. 3 . The phylogenetic tree calculated for all CAZy GH4 entries from Lactobacillus in addition to 6'-phospho-α-glucosidases with preference for 6'-phospho-maltose (EC 3.2.1.122). The amino acid sequences were retrieved and aligned using the MAFFT program and the phylogenetic tree was calculated using the ClustalW, both interfaced at the European Bioinformatics Institute (http://www.ebi.ac.uk/). The tree was rendered in Dendroscope (http://ab.inf.uni-tuebingen.de/software/dendroscope/). For clarity, not all sequences were displayed. The sequences forming the tree are labelled with their GenBank accession and some labels are omitted for clarity. The black subtree is populated by the GH4 sequence from L. acidophilus NCFM and L. casei ATCC334, which were implicated in the metabolism of isomaltose and sucrose isomers by transcriptomics (L. acidophilus NCFM) and proteomics (L. casei ATCC334; see Thompson et al. 2008) . The grey subtree contains the rest of lactobacilli GH4 sequences together with characterized 6'-phospho-α-glucosidases with preference for 6'-phospho-maltose (labelled with full organism names for clarity).
glycogen accumulation were carbon source-and growth phase-dependent, and were repressed by glucose . The highest intracellular glycogen content was observed in early-logarithmic phase cells grown on trehalose, which was followed by a drastic decrease of glycogen level prior to entering stationary phase. When the soybean tri-saccharide raffinose (6'-α-d-galactosyl-sucrose) was provided as the carbon source, glycogen accumulation in the cells gradually declined following early-log phase and was maintained at stable levels throughout stationary phase.
Raffinose also induced an overall higher temporal expression of the glg operon throughout growth compared to trehalose. Overall, unlike cells grown on trehalose or glucose, the raffinose-grown cells showed remarkably stable intracellular glycogen reserves during prolonged growth periods. It was speculated that L. acidophilus may maintain a higher level of intracellular glycogen to enhance sustainability when growing on a more complex carbon source, a scenario most likely encountered in the GI environment. These data prompted the proposal of a novel role conferred by raffinose and poten-tially other prebiotic oligosaccharides, namely the enhancement of the residence time of L. acidophilus in the GI tract by inducing the synthesis of glycogen storage reserves. Mutational analysis in L. acidophilus confirmed that glgA and glgB are responsible for glycogen biosynthesis and are required for efficient growth on raffinose. Furthermore, deletion of the glgB or glgP gene, which are involved in glycogen synthesis or degradation, respectively, resulted in defective growth and increased bile sensitivity. The study indicates that glycogen metabolism contributes to the growth maintenance, bile tolerance and efficient complex carbohydrate utilization in L. acidophilus, and reflects the importance of glycogen metabolism on the probiotic attributes of lactobacilli.
Perspectives
The explosive growth of metagenomic data and the myriad of studies exploring the interplay between the gut microbiota, certain diet types and the human host have yielded fascinating insight into the importance of gut microbiota and diet to human health. Manipulating the composition of the gut microbiota to promote health and diminish the use of antibiotics to combat enteropathogens, comprises an important objective that would be promoted by a better molecular understanding of glycan metabolism in the gut niche. Despite the importance of α-glucan metabolism, some fundamental aspects of it remain ill-understood. Future work addressing α-glucan uptake by different microbiota members is important to understand niche adaptation regarding competition and cross-feeding amongst different microbiota taxa. The enzymology and molecular recognition of several important players in α-glucan metabolism require more attention to establish a better understanding of the dynamic metabolic fluxes that may contribute to the flexibility and fitness of microbial cells in the competitive gut niche.
